Twin Focus Capital Partners’s Charles River Laboratories CRL Stock Holding History

Twin Focus Capital Partners’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-20,000	Closed	-$1.27M	–	93
2015 Q3	$1.27M	Hold	20,000	–	–	1.62%	14
2015 Q2	$1.41M	Hold	20,000	–	–	1.58%	15
2015 Q1	$1.59M	Hold	20,000	–	–	1.24%	12
2014 Q4	$1.27M	Buy	+20,000	New	+$1.25M	1.48%	11

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Twin Focus Capital Partners's CRL Position: Q4 2015 in Review

Twin Focus Capital Partners sold out of Charles River Laboratories (CRL) in Q4 2015, closing a stake of 20,000 shares — an estimated $1.27M sold.

Twin Focus Capital Partners first reported a position in CRL in Q4 2014 and held it in 4 quarters. The position peaked at $1.59M in Q1 2015. 268 funds tracked by Wall St. Rank hold CRL as of Q4 2015.

Twin Focus Capital Partners reported no remaining Charles River Laboratories position as of Q4 2015 after selling out during the quarter.
Twin Focus Capital Partners sold 20,000 Charles River Laboratories shares in Q4 2015, an estimated $1.27M.
Twin Focus Capital Partners first reported a position in Charles River Laboratories in Q4 2014 and held it in 4 quarters.
Twin Focus Capital Partners's Charles River Laboratories position peaked at $1.59M in Q1 2015.
268 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2015.

Based on Twin Focus Capital Partners's 13F filing for Q4 2015, filed 16 Feb 2016.